2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic DiseasesSindhu R. Johnson, Jake G. Natalini, Reza Mirza et al.|Arthritis & Rheumatology|2024Cited by 162
Nerandomilast in Patients with Progressive Pulmonary FibrosisToby M. Maher, Fernando J. Martínez, Shervin Assassi et al.|New England Journal of Medicine|2025Cited by 134
2023 American College of Rheumatology (<scp>ACR</scp>)/American College of Chest Physicians (<scp>CHEST</scp>) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic DiseasesSindhu R. Johnson, Jake G. Natalini, Elana J. Bernstein et al.|Arthritis & Rheumatology|2024Cited by 122
The Antifibrotic Effect of A<sub>2B</sub> Adenosine Receptor Antagonism in a Mouse Model of Dermal FibrosisHarry Karmouty‐Quintana, Tingting Weng, Jose G. Molina et al.|Arthritis & Rheumatology|2018Cited by 21